Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 20, Issue 6, 2001, Pages 766-771

  Johnson, D W ^a   Kay, T D ^a   Vesey, D A ^a   Isbel, N ^a   Campbell, S B ^a   Hawley, C M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Dialysis adequacy; Dialysis solutions; Homocysteine; Hyperhomocysteinemia; Kidney failure chronic therapy; Peritoneal transport; Pharmacokinetics

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; HOMOCYSTEINE; SERUM ALBUMIN; UREA;

ADULT; AGE; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; AUTOMATION; BLOOD SAMPLING; CLEARANCE; CLINICAL OBSERVATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSATE; EFFLUENT; ERYTHROCYTE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; PERITONEAL DIALYSIS; PERITONITIS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN DEPLETION;

EID: 0035116572     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000630     Document Type: Article

References (38)

1. Sulphur containing amino acids in chronic renal failure with particular reference to homocysteine and cysteine-homocysteine mixed disulphide
2. Concentrations of total homocysteine in plasma in chronic renal failure
3. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
4. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients
5. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
6. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis
7. Homocysteine: An emerging age-related cardiovascular risk factor
8. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study
9. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
10. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
11. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study
12. Hyperhomocysteinaemia is associated with arterial occlusive accidents in predialysis chronic renal failure patients
13. Net uptake of plasma homocysteine by the rat kidney in vivo
14. The role of homocysteine in end-stage renal disease
15. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
16. Folic acid treatment of hyperhomocysteinemia in dialysis patients
17. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
18. Homocysteine and folate concentrations in blood from patients treated with hemodialysis
19. Accumulation of sulphur-containing amino acids including cysteinehomocysteine in patients on maintenance haemodialysis
20. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis
21. Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis
22. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients
23. Plasma homocysteine in renal failure
24. Hyperhomocysteinaemia in dialysis patients and homocysteine clearances of different hemodialyzers
25. Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients
26. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients
27. Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysis patients
28. A formula to estimate the approximate surface area if height and weight be known
29. Total body water volumes for adult males and females estimated from simple anthropometric measurements
30. Peritoneal clearance of leptin in CAPD patients: Impact of local insulin administration
31. Glomerular filtration rate. Determination in patients with chronic renal disease
32. Peritoneal equilibration test
33. Is hyperhomocysteinaemia in haemodialysis patients associated with a mutation of the methylenetetrahydrofolate reductase (MHTFR) gene?
34. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
35. 12
36. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure
37. Does a high peritoneal transport rate reflect a state of chronic inflammation?
38. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial